Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug MAR001 targets high fat levels in blood

NCT ID NCT05896254

First seen Nov 14, 2025 · Last updated May 25, 2026 · Updated 26 times

Summary

This study tested a new drug called MAR001 in 55 adults with high triglycerides, a type of fat in the blood linked to metabolic problems. The main goal was to check if the drug is safe and tolerable. Researchers also looked at whether it lowers triglyceride levels. The study was placebo-controlled, meaning some participants got a dummy treatment for comparison.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Brisbane Site

    Brisbane, 4006, Australia

  • Melbourne Site

    Melbourne, 3004, Australia

Conditions

Explore the condition pages connected to this study.